| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Matthew Buten is Chief Financial Officer at BHVN. Matthew Buten's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.1M at current prices.
Net of sales, the BHVN filings show accumulation of 165,584 shares.
Matthew Buten has 8 Form 4 filings on record from October 2022 to February 2026, all as Chief Financial Officer at Biohaven (BHVN), 2022–2026.
The 19 reported transactions were 6 option or other derivative awards, 4 option exercises, 4 other transactions and 3 tax withholdings, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $2.0M and no sales.
The largest open-market purchase was 142,857 shares of BHVN at an average $10.50 on October 25, 2022, about $1.5M. Twelve months later BHVN was up 92%.